Status:
UNKNOWN
Adjunctive Vaginal Progesterone in Management of Preterm Labor
Lead Sponsor:
Chulalongkorn University
Conditions:
Preterm Labor
Eligibility:
FEMALE
18-45 years
Phase:
PHASE4
Brief Summary
This study evaluates the addition of vaginal micronized progesterone effervescent to standard treatment in the treatment of preterm labor. Half of participants will receive vaginal micronized progeste...
Eligibility Criteria
Inclusion
- singleton pregnancy with gestational age 24-33 weeks 6 days
- preterm labor
- received treatment with tocolysis and corticosteroids
Exclusion
- conditions that need immediate delivery such as fetal distress, chorioamnionitis
- have medical complications such as heart disease, seizure
- fetal anomalies
- cervical dilatation more than 5 cm
- allergy to progesterone
- contraindication to progesterone
- contraindication to tocolytic use
Key Trial Info
Start Date :
August 16 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT05997563
Start Date
August 16 2023
End Date
October 31 2025
Last Update
August 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vorapong Phupong
Bangkok, Thailand, 10330